Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000141

EVP, Chief Reg. & Quality Off. sold 4,058 shares at $485.49 ($1,970,118)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Tatsis Ourania · EVP, Chief Reg. & Quality Off.

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-03-04 Sale : show line 1 in the form 10b5-1 −4,058 $485.49 $1,970,118 54,481 D
Open-market sales · 4,058 sh · avg $485.49 · $1,970,118
Loading xslF345X05/wk-form4_1741295323.xml…